Filing Flows › National Health Investors (NHI) › Q2 2026 › vs Q1 2026
National Health Investors (NHI) Q2 2026 vs Q1 2026 (quarter over quarter)
National Health Investors's revenue rose $6.2M (+5%) from $115M in Q1 2026 to $121M in Q2 2026. Operating margin 46.2% against 34.5% (+11.7 pts).
National Health Investors, Q2 2026: revenue $121M (+34% year over year), operating margin 46.2%, net earnings $55.7M, operating cash flow $65.0M. The chart draws each line against Q1 2026, the increases inside each band.
Margins
| Q2 2026 | Q1 2026 | Change | |
|---|---|---|---|
| Operating margin | 46.2% | 34.5% | +11.7 pts |
| Net margin | 45.9% | 34.8% | +11.1 pts |
Every line
| Line | Q2 2026 | Q1 2026 | Change | % |
|---|---|---|---|---|
| Revenue | $121M | $115M | $6.2M | +5% |
| Operating profit | $56.1M | $39.8M | $16.3M | +41% |
| Costs & expenses | $65.2M | $75.4M | −$10.1M | -13% |
| Pre-tax earnings | $56.1M | $39.8M | $16.3M | +41% |
| General & admin | $8.8M | $7.9M | $972K | +12% |
| Other operating costs | $56.4M | $67.5M | −$11.1M | -16% |
| Loss borne by minority interests | $314K | $350K | −$36K | -10% |
| Net earnings | $55.7M | $40.1M | $15.6M | +39% |
| Income tax | $732K | $0 | $732K | — |
| Depreciation & amortization | $25.5M | $23.7M | $1.9M | +8% |
| Share-based compensation | $2.4M | $2.2M | $120K | +5% |
| Working capital & other | $18.6M | $12.6M | $6.0M | +48% |
| Operating cash flow | $65.0M | $53.4M | $11.5M | +22% |
Questions
How much did National Health Investors's revenue grow quarter over quarter in Q2 2026?
National Health Investors's revenue rose $6.2M (+5%) from $115M in Q1 2026 to $121M in Q2 2026. Operating margin 46.2% against 34.5% (+11.7 pts).